Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Providing Larger Stent Sizes to Interventional Cardiologists Means More Personalized Heart Health Therapies with Alex Nepogodiev Abbott Vascular TRANSCRIPT
Download PDFSep 7, 2022
Alex Nepogodiev is a Divisional Vice President of Abbott Vascular Business and shares insights about the need for stents with larger diameters. In the past, physicians would have to take a smaller diameter stent and follow up with another catheter to expand that stent to a larger size and to match the vessel. This procedure added an additional step and risk.
Alex explains, "Some of the bigger challenges today are, of course, the variation in anatomy and the complexity of some of those narrowings that we have in our heart. Cardiovascular disease, obviously, impacts a lot of patients, and myself included, and it's important for us not only to maintain good health but also go for appropriate and timely checkups. And when the cardiologist finds a narrowing in our heart, they initiate the procedure by first doing an x-ray or an angiogram before proceeding to insert a stent. And once they do that, they can also use other imaging modalities to look more closely at the vessel."
"So XIENCE Skypoint large vessel sizes have been introduced now with the largest size matrix and the new diameters that come in vessel sizes of 4.5 or 5.0 millimeters in diameter. And what they allow us to do is treat patients who may have larger vessels. We're all unique, and some of us are patients who are larger male or we have vessels that are closer to the aorta. So those tend to be larger in diameter as well. And having these larger vessel sizes allows the physicians to, again, optimize and personalize treatments to those particular situations in those patients."
@AbbottCardio #Stents #DrugElutingStents #InterventionalCardiologist #Cardiology #CardiovascularDisease
